Rocket Pharmaceuticals Inc header image

Rocket Pharmaceuticals Inc

RCKT

Equity

ISIN null / Valor 39764376

NASDAQ (2026-10-06)

USD 2.48-4.98%

Rocket Pharmaceuticals Inc
UMushroom community rating:

4.00 1 votes No rating yet

NegativeNeutralPositive

About company

Rocket Pharmaceuticals Inc. is a New York–based, Nasdaq‑listed clinical‑stage biotechnology company developing gene therapies for rare, inherited pediatric diseases. The firm advances both ex vivo lentiviral approaches—principally via genetically modified hematopoietic stem cells—and in vivo AAV‑based therapies, with clinical programs targeting hematologic, neuromuscular and cardiac genetic disorders. In addition to advancing multiple clinical candidates, Rocket operates internal vector manufacturing and development capabilities to support its trials and regulatory filings, positioning itself as a developer of durable, one‑time genetic interventions for severe monogenic conditions.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-22.0%1Y

-87.0%3Y

-91.4%5Y

Performance

70.5%1Y

91.6%3Y

85.1%5Y

Volatility

272 M

Market cap (USD)

1,790,517

Daily traded volume (Shares)

12.25 / 11.56

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

4.00

1 votes

Performance:

4.00

Innovation:

4.00

Society:

2.00

Nature:

2.00

Pascale Gonzalez

Switzerland, 16 Apr 2025

So la la

EQUITIES OF THE SAME SECTOR

IQVIA Holdings Inc

IQVIA Holdings Inc Valor: 39103858

Annual Return

-50%0%+50%

Risk level

110

-2.30%USD 259.98

Arvinas Inc

Arvinas Inc Valor: 43526042

Annual Return

-50%0%+50%

Risk level

110

-2.01%USD 7.31

AstraZeneca PLC

AstraZeneca PLC Valor: 982352

Annual Return

-50%0%+50%

Risk level

110

1.65%GBP 119.58

Smith & Nephew PLC

Smith & Nephew PLC Valor: 1103058

Annual Return

-50%0%+50%

Risk level

110

0.70%GBP 10.12

Envista Holdings Corporation

Envista Holdings Corporation Valor: 49153522

Annual Return

-50%0%+50%

Risk level

110

-0.30%USD 23.27

Humana Inc

Humana Inc Valor: 940174

Annual Return

-50%0%+50%

Risk level

110

0.05%USD 404.27

Hikma Pharmaceuticals PLC

Hikma Pharmaceuticals PLC Valor: 2324471

Annual Return

-50%0%+50%

Risk level

110

2.60%GBP 16.20

Indivior PLC

Indivior PLC Valor: 121550831

Annual Return

-50%0%+50%

Risk level

110

-0.67%GBP 27.04

Beximco Pharmaceuticals Ltd

Beximco Pharmaceuticals Ltd Valor: 2318407

Annual Return

-50%0%+50%

Risk level

110

0.00%GBP 0.54

Pharma Mar SA

Pharma Mar SA Valor: 56130572

Annual Return

-50%0%+50%

Risk level

110

0.93%EUR 70.30

SIX

FactSet

Clearbit

Logos provided by Clearbit